Search Results - "Prayongratana, K."

EXCELLENT OUTCOMES OF SUBCUTANEOUS PANNICULITIS‐LIKE T‐CELL LYMPHOMA TREATED WITH CYCLOSPORIN‐BASED REGIMEN, A MULTICENTER RETROSPECTIVE STUDY IN THAILAND by Noiperm, P., Julamanee, J., Lekhakula, A., Chansung, K., Sirijerachai, C., Norasetthada, L., Rattanathammethee, T., Prayongratana, K., Numbemjapon, T., Bunworasate, U., Wudhikarn, K., Wong, P., Chuncharunee, S., Niparuck, P., Siritanaratanakul, N., Khuhapinant, A., Jit‐Uaekul, D., Kanitsap, N., Wongkhantee, S., Makruasi, N., Kanya, P., Suwanban, T., Intragumtornchai, T.

Get full text

POLATUZUMAB VEDOTIN IN RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS: A MATCHED‐CONTROL ANALYSIS FROM THE THAI LYMPHOMA STUDY GROUP (TLSG) by Rattanathammethee, T., Norasetthada, L., Bunworasate, U., Wudhikarn, K., Julamanee, J., Noiperm, P., Lanamtieng, T., Phiphitaporn, P., Navinpipat, M., Kanya, P., Jit‐ueakul, D., Wongkhantee, S., Suwannathen, T., Chaloemwong, J., Wong, P., Makruasi, N., Khuhapinant, A., Prayongratana, K., Niparuck, P., Kanitsap, N., Suwanban, T., Intragumtornchai, T.

Get full text

CLINICAL CHARACTERISTICS AND OUTCOMES OF MYELODYSPLASTIC NEOPLASMS AND ACUTE MYELOID LEUKEMIA WITH MECOM REARRANGEMENT: RESULTS FROM A NATIONWIDE MULTICENTER STUDY by Polprasert, C., Chanswangphuwana, C., Owattanapanich, W., Kungwankiattichai, S., Rattarittamrong, E., Rattanathammethee, T., Tantiworawit, A., Limvorapitak, W., Saengboon, S., Niparuck, P., Puavilai, T., Julamanee, J., Saelue, P., Wanitpongpun, C., Nakhakes, C., Prayongratana, K., Karoopongse, E., Rojnuckarin, P., Sriswasdi, C.

“…“AML with MECOM rearrangement” was recently categorized by WHO classification 2022 regardless of blast count, which included those present with MDS and AML…”
Get full text

PB0067 Prognostic Value of the ISTH DIC Scoring System in Prediction of 28-Day Mortality in Hospitalized COVID-19 Pneumonia Patients by Thamgrang, T., Silpsamrit, P., Lamool, R., Prayongratana, K.

Get full text

PCN67 - Preference of Rituximab Subcutaneous (R-SC) in Thai Patients With Diffused Large B –Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Thai Context by Chansung, K, Chuncharunee, S, Khuhapinant, A, Bunworasate, U, Norasetthada, L, Prayongratana, K

Get full text

Preference of Rituximab Subcutaneous (R-SC) in Thai Patients With Diffused Large B –Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Thai Context by Chansung, K, Chuncharunee, S, Khuhapinant, A, Bunworasate, U, Norasetthada, L, Prayongratana, K

Get full text

PB1784 BCL‐2 EXPRESSION IS A GOOD PREDICTOR OF PROGNOSIS FOR PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA by Jandamnernpong, W., Prayongratana, K., Satayasoontorn, K., Laoruangroj, C., Leelasiri, A., Prayoonwiwat, W.

“…Background: Although diffuse large B cell lymphoma (DLBCL) is the most common subtype of lymphoma in all ethnic groups, it is highly heterogeneous in term of…”
Get full text